首页> 外文期刊>Implementation Science >Clinical performance comparators in audit and feedback: a review of theory and evidence
【24h】

Clinical performance comparators in audit and feedback: a review of theory and evidence

机译:审计和反馈中的临床表现比较器:理论与证据综述

获取原文
           

摘要

Audit and feedback (A&F) is a common quality improvement strategy with highly variable effects on patient care. It is unclear how A&F effectiveness can be maximised. Since the core mechanism of action of A&F depends on drawing attention to a discrepancy between actual and desired performance, we aimed to understand current and best practices in the choice of performance comparator. We described current choices for performance comparators by conducting a secondary review of randomised trials of A&F interventions and identifying the associated mechanisms that might have implications for effective A&F by reviewing theories and empirical studies from a recent qualitative evidence synthesis. We found across 146 trials that feedback recipients' performance was most frequently compared against the performance of others (benchmarks; 60.3%). Other comparators included recipients' own performance over time (trends; 9.6%) and target standards (explicit targets; 11.0%), and 13% of trials used a combination of these options. In studies featuring benchmarks, 42% compared against mean performance. Eight (5.5%) trials provided a rationale for using a specific comparator. We distilled mechanisms of each comparator from 12 behavioural theories, 5 randomised trials, and 42 qualitative A&F studies. Clinical performance comparators in published literature were poorly informed by theory and did not explicitly account for mechanisms reported in qualitative studies. Based on our review, we argue that there is considerable opportunity to improve the design of performance comparators by (1) providing tailored comparisons rather than benchmarking everyone against the mean, (2) limiting the amount of comparators being displayed while providing more comparative information upon request to balance the feedback's credibility and actionability, (3) providing performance trends but not trends alone, and (4) encouraging feedback recipients to set personal, explicit targets guided by relevant information.
机译:审计和反馈(A&F)是一种常见的质量改进策略,对患者护理具有高度可变影响。目前尚不清楚A&F的有效性如何最大化。由于A&F的核心作用机制取决于提请注意实际和期望的性能之间的差异,我们旨在了解性能比较器选择的当前和最佳实践。我们通过对A&F干预的随机试验进行了次要审查并确定了通过审查最近的定性证据综合的理论和实证研究可能对有效A&F产生影响的相关机制来描述了绩效比较者的次要选择。我们发现,在146项试验中发现,反馈收件人的表现最常与他人的表现相比(基准; 60.3%)。其他比较器包括收件人随时间的性能(趋势; 9.6%)和目标标准(明确目标; 11.0%),13%的试验使用这些选项的组合。在采用基准的研究中,42%与平均性能相比。八(5.5%)试验提供了使用特定比较器的理由。我们从12个行为理论,5项随机试验和42项定性A&F研究中蒸馏出每个比较器的机制。出版文学中的临床表现比较器受到理论知之甚少,并未明确占定性研究中报告的机制。根据我们的审核,我们认为,通过(1)提供了适当的机会,通过(1)提供量身定制的比较,而不是基于对平均值的基准测试,(2)限制在提供更多比较信息的同时展示的比较量请求平衡反馈的可信度和可行性,(3)提供性能趋势,但不是单独的趋势,(4)鼓励反馈收件人设定有关信息指导的个人,明确的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号